- Home
- NYXH vs OPRX Comparison
NYXH vs OPRX Comparison
Compare NYXH & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYXH | OPRX |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.0M | 120.1M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | NYXH | OPRX |
|---|---|---|
| Price | $1.60 | $4.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $9.33 | ★ $16.67 |
| AVG Volume (30 Days) | ★ 490.0K | 300.4K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $109,429,000.00 |
| Revenue This Year | $213.98 | $3.88 |
| Revenue Next Year | $126.25 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 18.78 |
| 52 Week Low | $1.26 | $4.57 |
| 52 Week High | $8.59 | $22.25 |
Technical Indicators
Market Signals| Indicator | NYXH | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 31.52 | 41.09 |
| Support Level | $1.26 | $4.92 |
| Resistance Level | $3.43 | $5.61 |
| Average True Range (ATR) | 0.19 | 0.30 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 18.89 | 8.49 |
Price Performance
Historical ComparisonAbout NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.